See All Slides - tctmd.com

Slides

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Presenter: Philippe Pibarot

September 26, 2019

Presentation TCT 2019

Case #4: OCT-Guided Laser Therapy in ISR

Presenter: Peter O'Kane

September 26, 2019

Presentation TCT 2019

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Presenter: Jay Giri

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients in Japan

Presenter: Yasuko Nakamura

September 26, 2019

Featured Technological Trends - How the Use of Noninvasive Cardiac Output Measurement Can (Could) Help You Manage Your Heart Failure Patient (Vital Metrix)

Presentation TCT 2019

How the Use of Noninvasive Cardiac Output Measurement Can (Could) Help You Manage Your Heart Failure Patient (Vital Metrix)

Presenter: James Heywood

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

Is There a Role for Coronary Physiology in Patients Referred for CABG?

Presenter: Petr Kala

September 26, 2019

Featured Technological Trends - A First-in-Human, Multicenter Open-Label Prospective Study to Evaluate the Safety, Usability, and Performance of the V-Lap System

Presentation TCT 2019

A First-in-Human, Multicenter Open-Label Prospective Study to Evaluate the Safety, Usability, and Performance of the V-Lap System

Presenter: William Abraham

September 26, 2019

Presentation TCT 2019

Case #3: Same Strategy With or Without OCT in ISR?

Presenter: Colm Hanratty

September 26, 2019

Advertisement

Slides

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Case #4: OCT-Guided Laser Therapy in ISR

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Study Design Considerations for HBR Patients in Japan

How the Use of Noninvasive Cardiac Output Measurement Can (Could) Help You Manage Your Heart Failure Patient (Vital Metrix)

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Is There a Role for Coronary Physiology in Patients Referred for CABG?

A First-in-Human, Multicenter Open-Label Prospective Study to Evaluate the Safety, Usability, and Performance of the V-Lap System

Case #3: Same Strategy With or Without OCT in ISR?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content